niacinamide has been researched along with cardiovascular agents in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coldwell, MC; Cooper, SM; Hamilton, TC; Howlett, DR; Wilson, C | 1 |
| SUTER, H | 1 |
| APPIANI, L; ZEMA, V | 1 |
| Abraham, NG; Baldi, S; Barsacchi, R; Drummond, GS; L'Abbate, A; Masiello, P; McClung, JA; Neglia, D; Novelli, M; Ottaviano, V; Paolicchi, A; Vecoli, C | 1 |
4 other study(ies) available for niacinamide and cardiovascular agents
| Article | Year |
|---|---|
Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Benzopyrans; Cardiovascular Agents; Cromakalim; Guanidines; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Pinacidil; Potassium Channels; Procaine; Pyrroles; Rabbits; Rubidium Radioisotopes; Tetraethylammonium Compounds; Vasodilator Agents | 1988 |
[N-(1-Phenylheptyl)-nicotinamide (Lytosin) and more new derivatives of nicotinamide].
Topics: Cardiovascular Agents; Humans; Muscle Relaxants, Central; Niacinamide | 1963 |
[Clinical study of a new spasmolytic (Lytosin) with particular reference to obstetrics and gynecology].
Topics: Biomedical Research; Cardiovascular Agents; Gynecology; Muscle Relaxants, Central; Niacinamide; Obstetrics; Parasympatholytics | 1963 |
Beneficial effect of heme oxygenase-1 expression on myocardial ischemia-reperfusion involves an increase in adiponectin in mildly diabetic rats.
Topics: Adiponectin; Animals; bcl-X Protein; Cardiovascular Agents; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Enzyme Induction; Heme Oxygenase (Decyclizing); Lactic Acid; Male; Malondialdehyde; Microcirculation; Myocardial Reperfusion Injury; Myocardium; Niacinamide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Protoporphyrins; Rats; Rats, Wistar; Severity of Illness Index; Streptozocin; Superoxides; Time Factors; Up-Regulation; Vascular Resistance; Vasoconstriction | 2007 |